首页>
外国专利>
TREATMENT OF PATIENTS AT ELEVATED CARDIOVASCULAR RISK WITH A COMBINATION OF A CHOLESTEROL-LOWERING AGENT, AN INHIBITOR OF THE RENIN-ANGIOTENSIN SYSTEM, AND ASPIRIN
TREATMENT OF PATIENTS AT ELEVATED CARDIOVASCULAR RISK WITH A COMBINATION OF A CHOLESTEROL-LOWERING AGENT, AN INHIBITOR OF THE RENIN-ANGIOTENSIN SYSTEM, AND ASPIRIN
展开▼
机译:降低胆固醇的药物,肾素-血管紧张素系统的抑制剂和阿司匹林的联合治疗高心血管疾病风险的患者
展开▼
页面导航
摘要
著录项
相似文献
摘要
Methods and compositions are provided for reducing the risk of cardiovascular events in individuals who are at elevated cardiovascular risk, including individuals who have systemic lupus erythematosus. The methods comprise administering a combination of: a cholesterol-lowering agent, such as an HMG CoA reductase inhibitor; an inhibitor of the renin-angiotensin system, such as an ACE inhibitor; aspirin; and optionally one or more of vitamin B6, vitamin B12, and folic acid. Pharmaceutical formulations combining all the active agents in unit-dose form for once-daily dosing are provided.
展开▼